progression

Cabozantinib after progression of kidney cancer improves survival

By Sharon Deveson Kell|2021-11-19T08:25:18+00:0019 Nov 2021|Drug treatments|

In a recent study, the use of cabozantinib after progression [...]

Comments Off

ASCO GU 2021: Long-term follow-up of kidney cancer patients on nivolumab plus ipilimumab combination

By Sharon Kell|2021-02-12T10:16:05+00:0012 Feb 2021|Drug treatments|

Long-term follow-up data from the CheckMate-214 study of the nivolumab [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org